Chronic regulation of arterial blood pressure by ANP: role of endogenous vasoactive endothelial factors.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  American Journal of Physiology. Heart and Circulatory Physiology

• Publication date

  1998-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1152/ajpheart.1998.275.5.H1826PMID 29592235
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Natriuretic peptide receptor 1 expression influences blood pressures of mice in a dose-dependent manner.

  1998cited by this paper
• Salt-sensitive hypertension in ANP knockout mice: potential role of abnormal plasma renin activity.

  1998cited by this paper
• Endogenous atrial natriuretic peptide inhibits endothelin-1 secretion in dogs with severe congestive heart failure.

  1996cited by this paper
• Salt-resistant hypertension in mice lacking the guanylyl cyclase-A receptor for atrial natriuretic peptide

  1995cited by this paper
• Genetic decreases in atrial natriuretic peptide and salt-sensitive hypertension

  1995cited by this paper
• Endothelium as an endocrine organ.

  1995cited by this paper
• Inhibition of endothelial nitric oxide synthase activity by protein kinase C.

  1995cited by this paper
• Localization of atrial natriuretic factor receptors in the mesenteric arterial bed. Comparison with angiotensin II and endothelin receptors.

  1995cited by this paper
• Atrial and brain natriuretic peptides stimulate the production and secretion of C-type natriuretic peptide from bovine aortic endothelial cells.

  1995cited by this paper
• Atrial natriuretic factor modulates nitric oxide production: an ANF-C receptor-mediated effect

  1995cited by this paper
• Blood pressure and fluid-electrolyte balance in ANF-transgenic mice on high- and low-salt diets.

  1995cited by this paper
• Reciprocal regulation of endothelin-1 and endothelial constitutive NOS in proliferating endothelial cells.

  1995cited by this paper
• Regulation of vascular smooth muscle soluble guanylate cyclase activity, mRNA, and protein levels by cAMP-elevating agents.

  1995cited by this paper
• Up‐regulation of endothelial nitric oxide synthase expression by cyclic guanosine 3′,5′‐monophosphate

  1995cited by this paper
• In vivo pharmacological characterization of the non‐peptide endothelin receptor antagonist SB 209670

  1995cited by this paper
• Natriuretic Peptide Receptor-B (Guanylyl Cyclase-B) Mediates C-type Natriuretic Peptide Relaxation of Precontracted Rat Aorta (*)

  1995cited by this paper
• Role of natriuretic peptide clearance receptor in in vivo control of C-type natriuretic peptide.

  1995cited by this paper
• Requirement for prostaglandin synthesis in secretion of atrial natriuretic factor from isolated rat heart.

  1995cited by this paper
• Phenotypic change of endothelin receptor subtype in cultured rat vascular smooth muscle cells.

  1994cited by this paper
• Hemodynamics in transgenic mice with overexpression of atrial natriuretic factor.

  1994cited by this paper
• Cardiovascular actions of ANF: contributions of renal, neurohumoral, and hemodynamic factors in sheep.

  1993cited by this paper
• Cellular mechanism of natriuretic peptides-induced inhibition of endothelin-1 biosynthesis in rat endothelial cells.

  1993cited by this paper
• Distribution of C-type natriuretic peptide and its messenger RNA in rat central nervous system and peripheral tissue.

  1993cited by this paper
• Characterization and localization of endothelial nitric oxide synthase using specific monoclonal antibodies.

  1993cited by this paper
• Phosphorylation and subcellular translocation of endothelial nitric oxide synthase.

  1993cited by this paper
• Genomic analysis and expression patterns reveal distinct genes for endothelial and brain nitric oxide synthase.

  1993cited by this paper
• Atrial natriuretic factor receptors and signal transduction mechanisms.

  1993cited by this paper
• Atrial natriuretic peptide inhibits the production and secretion of endothelin from cultured endothelial cells. Mediation through the C receptor.

  1992cited by this paper
• Atrial and brain natriuretic peptides inhibit the endothelin-1 secretory response to angiotensin II in porcine aorta.

  1992cited by this paper
• Organ distribution of the three rat endothelin messenger RNAs and the effects of ischemia on renal gene expression.

  1992cited by this paper
• Chronic vs. acute hemodynamic effects of atrial natriuretic factor in conscious rats.

  1991cited by this paper
• Cyclic GMP down-regulates atrial natriuretic peptide receptors on cultured vascular endothelial cells.

  1991cited by this paper
• Interactions between endothelin and atrial natriuretic factor in the rat aortic ring preparation.

  1991cited by this paper
• Ring-deleted analogs of atrial natriuretic factor inhibit adenylate cyclase/cAMP system. Possible coupling of clearance atrial natriuretic factor receptors to adenylate cyclase/cAMP signal transduction system.

  1990cited by this paper
• Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme.

  1990cited by this paper
• Regulatory functions of the vascular endothelium.

  1990cited by this paper
• Mechanisms of atrial natriuretic factor-induced vasodilation.

  1990cited by this paper
• Regional and cardiac haemodynamic effects of NG‐nitro‐l‐arginine methyl ester in conscious, Long Evans rats

  1990cited by this paper
• Lack of an effect of atrial natriuretic peptide on myogenic contraction of microvascular smooth muscle.

  1990cited by this paper
• Atrial natriuretic peptide (ANP) does not inhibit the basal vascular tone present in the in situ blood-perfused dog gracilis muscle.

  1990cited by this paper
• Atrial natriuretic factor and endothelin interactions in control of vascular tone.

  1990cited by this paper
• Hypotension in transgenic mice expressing atrial natriuretic factor fusion genes.

  1990cited by this paper
• Autoradiographic Localization of [125I]Endothelin‐1 and [125I]Atrial Natriuretic Peptide in Rat Tissue: A Comparative Study

  1989cited by this paper
• Endothelin: visualization of mRNAs by in situ hybridization provides evidence for local action.

  1989cited by this paper
• Long-term hemodynamic actions of atrial natriuretic factor (99-126) in conscious sheep.

  1988cited by this paper
• Divergence of ANF analogs in smooth muscle cell cGMP response and aorta vasorelaxation: evidence for receptor subtypes.

  1987cited by this paper
• Identification of multiple binding sites for atrial natriuretic factor by affinity cross-linking in cultured endothelial cells.

  1986cited by this paper
• Synthetic atrial natriuretic factor does not dilate resistance-sized arteries.

  1986cited by this paper
• Long‐Term Hypotensive and Renal Effects of Atrial Natriuretic Peptide

  1986cited by this paper
• Comparison of binding and cyclic GMP accumulation by atrial natriuretic peptides in endothelial cells.

  1986cited by this paper

• Cardiovascular Consequences of Acute Kidney Injury: Treatment Options

  2023cites this paper
• Cardiac and Vascular Remodeling After 6 Months of Therapy With Sacubitril/Valsartan: Mechanistic Insights From Advanced Echocardiographic Analysis

  2022cites this paper
• Angiotensin receptor-neprilysin inhibitors: Comprehensive review and implications in hypertension treatment

  2021cites this paper
• Effects of Sacubitril/Valsartan (LCZ696) on Natriuresis, Diuresis, Blood Pressures, and NT-proBNP in Salt-Sensitive Hypertension

  2017cites this paper
• Heart failure and kidney Crucial & Common pathophysiological pathways

  2017cites this paper
• Elucidating the Mechanical, Structural, Functional, and Molecular Mechanisms Involved in Irreversible Vascular Changes in Aortic Coarctation

  2017cites this paper
• New Pharmacological Strategies to Increase cGMP.

  2016cites this paper
• Cardiorenal Signaling Pathways in Heart Failure: Good and Bad News

  2016cites this paper
• Pathophysiology and the cardiorenal connection in heart failure. Circulating hormones: biomarkers or mediators.

  2015cites this paper
• Mechanism underlying the anticontractile effect of perivascular adipose tissue

  2014cites this paper
• Atrial natriuretic peptide and regulation of vascular function in hypertension and heart failure: implications for novel therapeutic strategies.

  2013cites this paper
• Endothelial permeability in vitro and in vivo: protective actions of ANP and omapatrilat in experimental atherosclerosis.

  2013cites this paper
• Effects of ozone and particulate matter on cardiac mechanics: role of the atrial natriuretic peptide gene.

  2013cites this paper
• Экспертное мнение по гендерной тематике: «ахиллесова пята» современной журналистики

  2013cites this paper
• New aspects of the interactions between the cardiovascular nitric oxide system and natriuretic peptides.

  2011cites this paper
• Chronic endothelium-dependent regulation of arterial blood pressure by atrial natriuretic peptide: role of nitric oxide and endothelin-1.

  2009cites this paper
• Increased levels of C-type natriuretic peptide in patients with idiopathic left ventricular dysfunction.

  2007cites this paper
• Regulation of atrial natriuretic peptide secretion by a novel Ras-like protein

  2007cites this paper
• Reciprocal regulation of human soluble and particulate guanylate cyclases in vivo

  2006cites this paper
• Enhanced Inhibition of Neointimal Hyperplasia by Genetically Engineered Endothelial Progenitor Cells

  2004cites this paper
• Vascular natriuretic peptide receptor‐linked particulate guanylate cyclases are modulated by nitric oxide–cyclic GMP signalling

  2003cites this paper
• Gene Therapy Strategy for Long-Term Myocardial Protection Using Adeno-Associated Virus-Mediated Delivery of Heme Oxygenase Gene

  2002cites this paper
• Targeted disruption of the gene for natriuretic peptide receptor-A worsens hypoxia-induced cardiac hypertrophy.

  2002cites this paper
• Jcb: Article Introduction

  2002cites this paper
• Salmon cardiac peptide (sCP): a new model for natriuretic peptide biology

  2001cites this paper
• SALMON CARDIAC PEPTIDE (sCP): A NEW MODEL FOR NATRIURETIC PEPTIDE BIOLOGY

  2001cites this paper
• ANP in regulation of arterial pressure and fluid-electrolyte balance: lessons from genetic mouse models.

  2000cites this paper
• Aldosterone, a New Appreciation of Its Role in Heart Failure

  2000cites this paper
• Increased central AT(1)-receptor activation, not systemic vasopressin, sustains hypertension in ANP knockout mice.

  2000cites this paper
• Atrial Natriuretic Peptide: Regulator of Chronic Arterial Blood Pressure.

  2000cites this paper
• Chronic regulation of arterial blood pressure in ANP transgenic and knockout mice: role of cardiovascular sympathetic tone.

  1999cites this paper
• Chronic hypertension in ANP knockout mice: contribution of peripheral resistance.

  1999cites this paper
• Effect of saline infusion on kidney and collecting duct function in atrial natriuretic peptide (ANP) gene "knockout" mice.

  1999cites this paper